Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

EPHB2 overexpressed in malignant pleural mesothelioma cell lines, find researchers

Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options. Despite advances in the treatment, the median survival remains 12 months from the time of diagnosis. Increased understanding of the molecular basis for the diverse signaling pathways involved in cancer progression should promote the discovery of novel biomarkers for early diagnosis and potentially lead to more effective therapeutic tools for the disease.

26 Jul 2013

Teva, Lonza decide to discontinue biosimilars collaboration

Teva Pharmaceutical Industries and Lonza Group today announced that following a strategic review of the Teva-Lonza Joint Venture (TL-JV), the companies have decided to discontinue their collaboration for the development, manufacturing and marketing of biosimilars.

25 Jul 2013

Psychiatry professor selected for Robert Wood Johnson Foundation Health Policy Fellow 2013-2014

For millions of people across the United States, health and well-being depends on policy decisions made at the federal level. With mental health at the center of today's health policy discussion, Amir Afkhami, M.D., Ph.D., assistant professor of psychiatry and behavioral sciences and global health at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), will bring his "boots on the ground" experience in mental health policy to the government as a 2013-2014 Robert Wood Johnson Foundation Health Policy Fellow.

25 Jul 2013

Researchers to study knowledge and satisfaction of women who choose DNA prenatal screening test

A recently available DNA-based prenatal blood test used to screen pregnancies for Down syndrome and similar chromosome abnormalities in high-risk women is moving a step closer to use in the general pregnancy population.

From Natera 25 Jul 2013

Randomized trial examines purging of tumor cells from stem cells prior to transplantation in neuroblastoma patients

Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.

25 Jul 2013

Researchers find that Notch signaling elevated in tumors relative to normal bone

Many cancers show inappropriate activation of a cell signaling pathway called NOTCH. In the developing body, NOTCH tells brain cells to grow and proliferate. It should be quiet in the adult body, but cancers restart NOTCH to drive their own growth, far and beyond the rate of healthy tissues.

25 Jul 2013

New clinic focuses on men with fast-growing prostate cancer

While every year about 30,000 men die of prostate cancer in the United States, the most common cause of death in men with prostate cancer is heart disease. That's because not all prostate cancers are the same. Some are slow-growing while others are very aggressive.

25 Jul 2013

OracleBio to highlight Oncology image analysis expertise at Tumor Models conference

OracleBio, providers of high precision digital image analysis services for detailed quantification of histological marker staining within cells and tissues, is pleased to announce it will be a principal sponsor of the forthcoming Tumor Models conference to be held in Boston, MA on the 23-25th July.

24 Jul 2013

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Back in the early 1960s, just before chemotherapy really started to be used, only about 30% of children survived cancer. That was mainly because they had cancers that were amenable to surgery.

24 Jul 2013

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Inovio Pharmaceuticals, Inc. announced today that in a preclinical study with two animal models, Inovio's hTERT (human telomerase reverse transcriptase) DNA cancer vaccine administered with Inovio's CELLECTRA adaptive electroporation delivery technology generated robust and broad immune responses, broke the immune system's tolerance to its self-antigens, induced T-cells with a tumor-killing function, and increased the rate of survival.

24 Jul 2013

Study: Breathing oxygen during radiation therapy can delay tumor growth

A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.

24 Jul 2013

SCCA physicians honored as "Top Doctors" for providing outstanding cancer care

Seattle Cancer Care Alliance doctors were recently honored by a judging panel of their peers for providing outstanding cancer care.

24 Jul 2013

Research team receives NCI grant to develop precision therapies that kill cancer cells

A research team headed by Fred Hutchinson Cancer Research Center scientists Christopher Kemp, Ph.D., and Carla Grandori, M.D., Ph.D., has received a $4 million grant from the National Cancer Institute to develop precision therapies that selectively kill cancer cells while sparing normal, healthy tissue.

24 Jul 2013

Clinical trial finds that sleep quality impacts skin function and aging

In a first-of-its-kind clinical trial, physician-scientists at University Hospitals (UH) Case Medical Center found that sleep quality impacts skin function and aging.

24 Jul 2013

Incentives for Ontario surgeons drive greater use of laparoscopic colon cancer surgery

Financial incentives for Ontario surgeons are likely a key factor driving greater use of laparoscopic colon cancer surgery, says a study led by a McMaster University surgeon.

23 Jul 2013

Study documents reversal of established medical practices in last decade

While there is an expectation that newer medical practices improve the standard of care, the history of medicine reveals many instances in which this has not been the case. Reversal of established medical practice occurs when new studies contradict current practice. Reporters may remember hormone replacement therapy as an example of medical reversal. A new analysis published in Mayo Clinic Proceedings documents 146 contemporary medical practices that have subsequently been reversed.

23 Jul 2013

Loyola to start construction on $137M medical research and education building in August

Loyola University Chicago will break ground Aug. 16 on a $137 million medical research and education building to support nearly 500 scientists and staff working together to improve human health.

23 Jul 2013

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

P53 is a tumor suppressor gene. The gene encodes for a protein that monitors the state of the cell. If something goes wrong, it stops the cell from dividing or causes the cell to commit suicide. I call it the “guardian of the genome” as it is the molecule that seems to keep cells normal. It is one of our big defenses against cancer.

22 Jul 2013

Moberg Pharma granted exclusive rights to market Kerasal Nail in China

Moberg Pharma AB today announced that Menarini Asia-Pacific, a member of the Menarini Group - a top 40 global pharmaceutical company - has been granted the exclusive rights to market and sell Kerasal Nail in China. The companies now intend to seek marketing authorization for the product in the Chinese market.

22 Jul 2013

Cedars-Sinai's first accredited Complex Surgical Oncology Fellowship program established

The Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute has established the medical center's first accredited Complex Surgical Oncology Fellowship program, joining an elite group of 16 U.S. hospitals that have received accreditation for this type of training from the Accreditation Council for Graduate Medical Education, a premier evaluator of physician education programs.

22 Jul 2013

Oncology News and Research

Further Reading

EPHB2 overexpressed in malignant pleural mesothelioma cell lines, find researchers

Teva, Lonza decide to discontinue biosimilars collaboration

Psychiatry professor selected for Robert Wood Johnson Foundation Health Policy Fellow 2013-2014

Researchers to study knowledge and satisfaction of women who choose DNA prenatal screening test

Randomized trial examines purging of tumor cells from stem cells prior to transplantation in neuroblastoma patients

Researchers find that Notch signaling elevated in tumors relative to normal bone

New clinic focuses on men with fast-growing prostate cancer

OracleBio to highlight Oncology image analysis expertise at Tumor Models conference

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Study: Breathing oxygen during radiation therapy can delay tumor growth

SCCA physicians honored as "Top Doctors" for providing outstanding cancer care

Research team receives NCI grant to develop precision therapies that kill cancer cells

Clinical trial finds that sleep quality impacts skin function and aging

Incentives for Ontario surgeons drive greater use of laparoscopic colon cancer surgery

Study documents reversal of established medical practices in last decade

Loyola to start construction on $137M medical research and education building in August

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

Moberg Pharma granted exclusive rights to market Kerasal Nail in China

Cedars-Sinai's first accredited Complex Surgical Oncology Fellowship program established

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News